{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T04:21:41Z","timestamp":1684642901240},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s10038-018-0452-9","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T08:55:27Z","timestamp":1524819327000},"page":"831-839","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic variants in chemokine CC subfamily genes influence hepatitis C virus viral clearance"],"prefix":"10.1038","volume":"63","author":[{"given":"Yinan","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozhi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"452_CR1","unstructured":"WHO. Global hepatitis report, 2017. Geneva: WHO; 2017."},{"key":"452_CR2","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58\u201368.","journal-title":"J Hepatol"},{"key":"452_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958\u201365.","journal-title":"Lancet"},{"key":"452_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2893.2008.01012.x","volume":"16","author":"S Zeuzem","year":"2009","unstructured":"Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, Wedemeyer H, et al. Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat. 2009;16:75\u201390.","journal-title":"J Viral Hepat"},{"key":"452_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jama.284.4.450","volume":"284","author":"DL Thomas","year":"2000","unstructured":"Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450\u20136.","journal-title":"JAMA"},{"key":"452_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7326\/0003-4819-158-4-201302190-00003","volume":"158","author":"P Duggal","year":"2013","unstructured":"Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013;158:235\u201345.","journal-title":"Ann Intern Med"},{"key":"452_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/hep.20139","volume":"39","author":"B Gao","year":"2004","unstructured":"Gao B, Hong F, Radaeva S. Host factors and failure of interferon\u2010\u03b1 treatment in hepatitis C virus. Hepatology. 2004;39:880\u201390.","journal-title":"Hepatology"},{"key":"452_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/hep.22543","volume":"48","author":"H Shirakawa","year":"2008","unstructured":"Shirakawa H, Matsumoto A, Joshita S, Komatsu M, Tanaka N, Umemura T, et al. Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. Hepatology. 2008;48:1753\u201360.","journal-title":"Hepatology"},{"key":"452_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","volume":"139","author":"M Honda","year":"2010","unstructured":"Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, et al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology. 2010;139:499\u2013509.","journal-title":"Gastroenterology"},{"key":"452_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O\u2019hUigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461:798\u2013801.","journal-title":"Nature"},{"key":"452_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","volume":"138","author":"A Rauch","year":"2010","unstructured":"Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology. 2010;138:1338\u201345.","journal-title":"Gastroenterology"},{"key":"452_CR12","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105\u20139.","journal-title":"Nat Genet"},{"key":"452_CR13","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-\u03b1 and ribavirin therapy. Nat Genet. 2009;41:1100\u20134.","journal-title":"Nat Genet"},{"key":"452_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng.2521","volume":"45","author":"L Prokunina-Olsson","year":"2013","unstructured":"Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013;45:164\u201371.","journal-title":"Nat Genet"},{"key":"452_CR15","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme R, Oldach D, Chang K-M, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395\u2013406.","journal-title":"J Exp Med"},{"key":"452_CR16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1084\/jem.20040774","volume":"200","author":"L Rivino","year":"2004","unstructured":"Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J. Chemokine receptor expression identifies pre-T helper (Th) 1, pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med. 2004;200:725\u201335.","journal-title":"J Exp Med"},{"key":"452_CR17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jhep.2012.05.016","volume":"57","author":"E Estrabaud","year":"2012","unstructured":"Estrabaud E, Vidaud M, Marcellin P, Asselah T. Genomics and HCV infection: progression of fibrosis and treatment response. J Hepatol. 2012;57:1110\u201325.","journal-title":"J Hepatol"},{"key":"452_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/gene.2013.15","volume":"14","author":"V Suppiah","year":"2013","unstructured":"Suppiah V, Armstrong N, O\u2019connor KS, Berg T, Weltman M, Abate M, et al. CCR5-[DELTA] 32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes Immun. 2013;14:286.","journal-title":"Genes Immun"},{"key":"452_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4314\/ajnt.v4i3.71023","volume":"4","author":"LKC Rouhou","year":"2011","unstructured":"Rouhou LKC, Gorgi YL, Skhiri HA, Aouadi H, Jendoubi-Ayed S, Sfar I, et al. Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection. Arab J Nephrol Transplant. 2011;4:117\u201324.","journal-title":"Arab J Nephrol Transplant"},{"key":"452_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jhep.2010.07.014","volume":"54","author":"JI Riezu-Boj","year":"2011","unstructured":"Riezu-Boj J-I, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, et al. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol. 2011;54:422\u201331.","journal-title":"J Hepatol"},{"key":"452_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2009.11.001","volume":"52","author":"F Gr\u00fcnhage","year":"2010","unstructured":"Gr\u00fcnhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, et al. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. J Hepatol. 2010;52:153\u20139.","journal-title":"J Hepatol"},{"key":"452_CR22","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1053\/gast.2002.33660","volume":"122","author":"RP Woitas","year":"2002","unstructured":"Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, et al. Frequency of the HIV-protective CC chemokine receptor 5-\u039432\/\u039432 genotype is increased in hepatitis C. Gastroenterology. 2002;122:1721\u20138.","journal-title":"Gastroenterology"},{"key":"452_CR23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/gut.2004.055699","volume":"54","author":"C Goulding","year":"2005","unstructured":"Goulding C, Murphy A, MacDonald G, Barrett S, Crowe J, Hegarty J, et al. The CCR5-\u039432 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source. Gut. 2005;54:1157\u201361.","journal-title":"Gut"},{"key":"452_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0168-8278(03)00193-4","volume":"39","author":"G Ahlenstiel","year":"2003","unstructured":"Ahlenstiel G, Berg T, Woitas RP, Gr\u00fcnhage F, Iwan A, He\u00df L, et al. Effects of the CCR5-\u039432 mutation on antiviral treatment in chronic hepatitis C. J Hepatol. 2003;39:245\u201352.","journal-title":"J Hepatol"},{"key":"452_CR25","doi-asserted-by":"publisher","first-page":"e0137365","DOI":"10.1371\/journal.pone.0137365","volume":"10","author":"K Thanapirom","year":"2015","unstructured":"Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, et al. Association between CXCL10 and DPP4 gene polymorphisms and a complementary role for unfavorable IL28B genotype in prediction of treatment response in Thai patients with chronic hepatitis C virus infection. PLoS ONE. 2015;10:e0137365.","journal-title":"PLoS ONE"},{"key":"452_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12876-017-0724-4","volume":"17","author":"CC Lin","year":"2017","unstructured":"Lin CC, Su SH, Jeng WJ, Huang CH, Teng W, Chen WT, et al. CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with Peg IFN\/RBV. BMC Gastroenterol. 2017;17:169.","journal-title":"BMC Gastroenterol"},{"key":"452_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147:577\u201394.e1.","journal-title":"Gastroenterology"},{"key":"452_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3109\/08830185.2011.593105","volume":"30","author":"A Katsounas","year":"2011","unstructured":"Katsounas A, Schlaak JF, Lempicki RA. CCL5: a double-edged sword in host defense against the hepatitis C virus. Int Rev Immunol. 2011;30:366\u201378.","journal-title":"Int Rev Immunol"},{"key":"452_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/187152811798104890","volume":"10","author":"H W Zimmermann","year":"2011","unstructured":"W Zimmermann H, Tacke F. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. Inflamm Allergy-Drug Targets. 2011;10:509\u201336.","journal-title":"Inflamm Allergy-Drug Targets"},{"key":"452_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/hep.510300147","volume":"30","author":"KF Yoong","year":"1999","unstructured":"Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Price K, et al. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by \u03b3\u2010interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology. 1999;30:100\u201311.","journal-title":"Hepatology"},{"key":"452_CR31","first-page":"1858","volume":"119","author":"E Seki","year":"2009","unstructured":"Seki E, De Minicis S, Gwak G-Y, Kluwe J, Inokuchi S, Bursill CA, et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. 2009;119:1858.","journal-title":"J Clin Invest"},{"key":"452_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/jgh.12462","volume":"29","author":"N Nguyen","year":"2014","unstructured":"Nguyen N, Esch C, Cameron B, Kumar RK, Zekry A, Lloyd AR. Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus\u2010infected liver correlates with local chemokine expression. J Gastroenterol Hepatol. 2014;29:860\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"452_CR33","first-page":"416","volume":"80","author":"S Han","year":"2012","unstructured":"Han S, Sa K, Kim S, Lee S, Park Y, Lee S, et al. CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis. HLA . 2012;80:416\u201323.","journal-title":"HLA"},{"key":"452_CR34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ajmg.b.32071","volume":"159","author":"AJ Levine","year":"2012","unstructured":"Levine AJ, Service S, Miller EN, Reynolds SM, Singer EJ, Shapshak P, et al. Genome\u2010wide association study of neurocognitive impairment and dementia in HIV\u2010infected adults. Am J Med Genet Part B. 2012;159:669\u201383.","journal-title":"Am J Med Genet Part B"},{"key":"452_CR35","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00415-009-5138-y","volume":"256","author":"C Villa","year":"2009","unstructured":"Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L, et al. CCL8\/MCP-2 association analysis in patients with Alzheimer\u2019s disease and frontotemporal lobar degeneration. J Neurol. 2009;256:1379\u201381.","journal-title":"J Neurol"},{"key":"452_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/QAI.0000000000000491","volume":"68","author":"D Pineda-Tenor","year":"2015","unstructured":"Pineda-Tenor D, Berenguer J, Garc\u00eda-\u00c1lvarez M, Guzm\u00e1n-Fulgencio M, Carrero A, Ald\u00e1miz-Echevarria T, et al. Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV\/HCV-co-infected patients. J Acquir Immune Defic Syndr. 2015;68:386\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"452_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jcv.2014.08.020","volume":"61","author":"D Pineda-Tenor","year":"2014","unstructured":"Pineda-Tenor D, Berenguer J, Jim\u00e9nez-Sousa MA, Guzm\u00e1n-Fulgencio M, Ald\u00e1miz-Echevarria T, Carrero A, et al. CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV\/HCV-co-infected patients. J Clin Virol. 2014;61:423\u20139.","journal-title":"J Clin Virol"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0452-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0452-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-018-0452-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:06:10Z","timestamp":1684616770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-018-0452-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["452"],"URL":"https:\/\/doi.org\/10.1038\/s10038-018-0452-9","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"26 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}